RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 76 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2014. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $537,000 | +68.9% | 59,833 | +0.9% | 0.00% | +100.0% |
| Q2 2016 | $318,000 | +16.5% | 59,306 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $273,000 | -11.4% | 59,306 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $308,000 | -14.2% | 59,306 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $359,000 | -61.6% | 59,306 | 0.0% | 0.00% | -57.1% |
| Q2 2015 | $936,000 | +77.3% | 59,306 | +22.1% | 0.01% | +75.0% |
| Q1 2015 | $528,000 | +3.3% | 48,574 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $511,000 | +9.7% | 48,574 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $466,000 | -16.9% | 48,574 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $561,000 | +15.4% | 48,574 | 0.0% | 0.00% | +33.3% |
| Q1 2014 | $486,000 | -24.2% | 48,574 | -1.3% | 0.00% | -40.0% |
| Q4 2013 | $641,000 | -11.6% | 49,196 | +1.4% | 0.01% | -16.7% |
| Q3 2013 | $725,000 | +84.0% | 48,530 | +15.3% | 0.01% | +100.0% |
| Q2 2013 | $394,000 | – | 42,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 888,132 | $7,966,000 | 6.12% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 1,054,678 | $9,460,000 | 3.30% |
| Kassirer Asset Management Corp | 363,700 | $3,262,000 | 2.36% |
| WATER ISLAND CAPITAL LLC | 3,359,140 | $30,131,000 | 1.91% |
| Banco BTG Pactual S.A. | 338,889 | $3,040,000 | 1.43% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 1,941,012 | $17,411,000 | 1.41% |
| FIRST NEW YORK SECURITIES LLC /NY | 237,500 | $2,130,375,000 | 1.41% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 3,804,600 | $34,089,000 | 1.25% |
| Atika Capital Management LLC | 300,000 | $2,691,000 | 1.10% |
| Atika Capital Management LLC | 298,200 | $2,672,000 | 1.09% |